Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems

Autor: Brian Chen, Ying Isabel Chen, Joseph P. Newhouse, Jianchao Quan, Janet Tinkei Lam, Karen Eggleston, Jui-fen Rachel Lu, Toshiaki Iizuka, Talitha L Feenstra, Jeroen N. Struijs, Gabriel M. Leung, Chih-Hung Chen, Beatriz Rodríguez-Sánchez
Přispěvatelé: PharmacoTherapy, -Epidemiology and -Economics
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: European Journal of Health Economics, 21(5), 689-702. Springer Verlag
European Journal of Health Economics, 21(5), 689-702. SPRINGER
ISSN: 1618-7601
1618-7598
Popis: Improvements in medical treatment have contributed to rising health spending. Yet there is relatively little evidence on whether the spending increase is “worth it” in the sense of producing better health outcomes of commensurate value—a critical question for understanding productivity in the health sector and, as that sector grows, for deriving an accurate quality-adjusted price index for an entire economy. We analyze individual-level panel data on medical spending and health outcomes for 123,548 patients with type 2 diabetes in four health systems: Japan, The Netherlands, Hong Kong and Taiwan. Using a “cost-of-living” method that measures value based on improved survival, we find a positive net value of diabetes care: the value of improved survival outweighs the added costs of care in each of the four health systems. This finding is robust to accounting for selective survival, end-of-life spending, and a range of values for a life-year or fraction of benefits attributable to medical care. Since the estimates do not include the value from improved quality of life, they are conservative. We, therefore, conclude that the increase in medical spending for management of diabetes is offset by an increase in quality.
Databáze: OpenAIRE
Externí odkaz: